Publications by authors named "Jaussent I"

Article Synopsis
  • Cardiovascular diseases are the leading cause of illness and death in chronic kidney disease patients, with a study analyzing the impact of coronary artery calcifications (CAC) and cardiovascular biomarkers on major adverse cardiovascular events and deaths.
  • The study involved 425 non-dialysis CKD patients who underwent scans for CAC scoring and measurement of various cardiovascular risk biomarkers, with follow-up lasting an average of about 3.6 years.
  • Findings indicate that high CAC levels significantly increase the risk of major adverse cardiovascular events, especially when combined with certain inflammatory and metabolic conditions, suggesting that managing inflammation and improving mineral metabolism could be key strategies for reducing cardiovascular risk in these patients.
View Article and Find Full Text PDF

Objective/background: Kleine-Levin syndrome (KLS) is a rare sleep disorder characterized by recurrent episodes of severe hypersomnolence in association with various degrees of cognitive impairment, perceptive abnormalities, apathy, behavioral disturbances. Some of these symptoms, hypersomnolence, compulsive eating and increased sexual drive may be replaced by their opposites or alternate with them. Remarkably enough, these « atypical symptoms » have never been enlighted nor compared in frequency with corresponding typical symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • Kleine-Levin syndrome (KLS) is a rare disorder characterized by recurring episodes of excessive sleepiness and cognitive/behavioral issues, potentially linked to inflammation, prompting a study on microglia activation using PET imaging.
  • Researchers conducted PET scans on KLS patients and controls, focusing on specific brain regions to measure microglial activation and compare conditions during symptomatic and asymptomatic phases.
  • The study found no significant differences in microglial activation between KLS patients and controls or between symptomatic and asymptomatic periods, suggesting a lack of neuroinflammation in KLS and indicating the need for further research on potential biomarkers.
View Article and Find Full Text PDF
Article Synopsis
  • Narcolepsy type 1 (NT1) is linked to the loss of orexin-producing neurons in the hypothalamus, potentially due to an immune response, but past studies showed no inflammation during later stages of the disease.
  • This research investigated microglia density in the hypothalamus and thalamus of NT1 patients using PET imaging, compared to control subjects, while also exploring relationships between microglial activity and disease factors like duration and severity.
  • Results indicated no significant differences in microglial density between NT1 patients and controls in the hypothalamus and thalamus, but lower overall brain microglial activity was observed in NT1 patients, raising questions about the disease's immune mechanisms and its onset
View Article and Find Full Text PDF

Study Objectives: Narcolepsy type 2 (NT2) is an understudied central disorder of hypersomnolence sharing some similarities with narcolepsy type 1 and idiopathic hypersomnia (IH). We aimed: (1) to assess systematically the symptoms in patients with NT2, with self-reported questionnaires: Epworth Sleepiness Scale (ESS), Narcolepsy Severity Scale (NSS), IH Severity Scale (IHSS), and (2) to evaluate the responsiveness of these scales to treatment.

Methods: One hundred and nine patients with NT2 (31.

View Article and Find Full Text PDF

Many studies suggest a relationship between excessive daytime sleepiness (EDS) and dementia incidence, but the underlying mechanisms remain uncertain. The study aimed to investigate the role of cardiovascular burden in the relationship between EDS and dementia incidence over a 12-year follow-up in community-dwelling older adults. We performed analyses on 6171 subjects (aged ≥65 years) free of dementia and vascular disease at baseline.

View Article and Find Full Text PDF
Article Synopsis
  • Sleep disturbances following ischaemic stroke can include issues like obstructive sleep apnea, insomnia, and restless legs syndrome, which may impact recovery.
  • In a study involving 90 stroke patients, severe obstructive sleep apnea was assessed and participants were divided into two groups: one receiving continuous positive airway pressure (CPAP) treatment and the other receiving a placebo.
  • Functional independence and other outcomes were measured at three months post-stroke, revealing no significant difference between CPAP and placebo in improving these scores, while factors like insomnia and decreased total sleep time correlated with poorer recovery.
View Article and Find Full Text PDF

Brain-derived neurotrophic factor (BDNF) is important for sleep physiology. This study investigates whether BDNF variants and promoter I methylation may be implicated in sleep disturbances in older adults. Genotyping was performed for seven BDNF single nucleotide polymorphisms (SNPs) in 355 community-dwelling older adults (aged ≥65 years) and BDNF exon 1 promoter methylation was measured in blood samples at baseline (n = 153).

View Article and Find Full Text PDF

Symptoms of restless legs syndrome are relieved by movement. Whether a cognitive task decreases sensory discomfort remains understudied. We aimed to assess the frequency of patients with restless legs syndrome who report decreased sensory discomfort during cognitive activities, and quantify this decrease during a cognitive task.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea syndrome (OSA) is common in patients with acute myocardial infarction (AMI). Whether OSA impacts on the ventricular remodeling post-AMI remains unclear. We compared cardiac ventricular remodeling in patients assessed by cardiac magnetic resonance (CMR) imaging at baseline and six months after AMI based on the presence and severity of OSA.

View Article and Find Full Text PDF

Study Objectives: To assess the performances of alternative measures of the multiple sleep latency test (MSLT) to identify hypocretin-deficiency in patients with a complaint of hypersomnolence, including patients with narcolepsy.

Methods: MSLT parameters from 374 drug-free patients with hypersomnolence, with complete clinical and polysomnographic (PSG) assessment and cerebrospinal hypocretin-1 measurement were collected. Conventional (sleep latency, number of sleep onset REM-SOREM-periods) and alternative (sleep duration, REM sleep latency and duration, sleep stage transitions) MSLT measures were compared as function of hypocretin-1 levels (≤110 vs > 110 pg/mL).

View Article and Find Full Text PDF

Background: given the complex relationship between sleep and neurodegenerative processes, it is important to examine whether changes in sleep patterns occur prior or close to dementia onset.

Objective: to examine the relationship between sleep parameters and dementia incidence and, to characterize trajectories of sleep patterns before dementia diagnosis.

Design: a 14-year longitudinal study including a nested case-control study.

View Article and Find Full Text PDF

Background And Objectives: To explore the first coronavirus disease 2019 (COVID-19) lockdown effect on sleep symptoms in patients with narcolepsy, idiopathic hypersomnia (IH), and restless legs syndrome (RLS).

Methods: Between March and May 2020, a sample of adult patients regularly followed up in a Reference Hospital Sleep Unit (299 with narcolepsy, 260 with IH, and 254 with RLS) was offered an online survey assessing their sleep-wake habits, daily activities, medication intake, and validated scales: International RLS Study Group questionnaire, Narcolepsy Severity Scale (NSS), IH Severity Scale (IHSS), Epworth Sleepiness Scale (ESS), Insomnia Severity Index, Beck Depression Inventory-II, and European Quality of Life (QoL) scale. The survey was proposed once, and the questions were answered for the prelockdown (recall of the month before the confinement) and the lockdown (time of study) periods.

View Article and Find Full Text PDF

Study Objectives: Despite its high frequency in narcolepsy type 1(NT1), disrupted nocturnal sleep (DNS) remains understudied, and its determinants have been poorly assessed. We aimed to determine the clinical, polysomnographic (PSG), and biological variables associated with DNS in a large sample of patients with NT1, and to evaluate the effect of medication on DNS and its severity.

Methods: Two hundred and forty-eight consecutive adult patients with NT1 (145 untreated, 103 treated) were included at the National Reference Center for Narcolepsy-France; 51 drug-free patients were reevaluated during treatment.

View Article and Find Full Text PDF

Background: Sleep disturbances are common in elderly and occur frequently in dementia. The impact of excessive daytime sleepiness (EDS), insomnia complaints, sleep quality, and hypnotics on the risk of all-cause dementia, Alzheimer disease (AD), and dementia with vascular component (DVC) remains unclear, as does the association between sleep profile and plasma β-amyloid levels.

Methods: Analyses were carried out on 6851 participants aged 65 years and over randomly recruited from three French cities and free of dementia at baseline.

View Article and Find Full Text PDF

Sleep disturbances are frequent among patients with heart failure (HF). We hypothesized that self-reported sleep disturbances are associated with a poor prognosis in patients with HF. A longitudinal study of 119 patients with HF was carried out to assess the association between sleep disturbances and the occurrence of major cardiovascular events (MACE).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of the Idiopathic Hypersomnia Severity Scale (IHSS) in measuring symptoms of idiopathic hypersomnia and to determine its psychometric reliability, as well as establish clinically relevant score differences.
  • Involving 226 patients, the research found that treated patients had significantly lower IHSS scores compared to untreated ones, with a minimum clinically important difference of 4 points identified.
  • The results confirmed that the IHSS is a valid tool for assessing symptoms and tracking changes post-treatment, with no need for item weighting, suggesting its usefulness in both clinical practice and research.
View Article and Find Full Text PDF

Study Objectives: Sleep inertia is a frequent and disabling symptom in idiopathic hypersomnia (IH), but poorly defined and without objective measures. The study objective was to determine whether the psychomotor vigilance task (PVT) can reliably measure sleep inertia in patients with IH or other sleep disorders (non-IH).

Methods: A total of 62 (51 women, mean age: 27.

View Article and Find Full Text PDF

Growing evidences indicate that sex hormones have an effect on cognitive functions, and that Bulimia Nervosa (BN) is associated with cognitive impairment. The aim of this study was to determine the effect of hormonal contraception (HC) use on four cognitive functions that are impaired in patients with BN. This retrospective exploratory study included 103 women with a diagnosis of BN based on the DSM-5 criteria.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to validate the Pediatric Narcolepsy Severity Scale (NSS-P) for measuring symptoms in children and adolescents with narcolepsy type 1 (NT1), replacing the adult version's driving-related item.
  • A total of 209 participants aged 6-17 were involved, with 160 completing the NSS-P fully; results showed the NSS-P has strong psychometric properties and effectively captures symptom severity changes linked to treatment.
  • Findings indicated the NSS-P could reliably distinguish between severity levels of NT1 and was associated with other symptoms like sleepiness and depression, supporting its use in clinical assessments.
View Article and Find Full Text PDF